iBio

iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. It operates through the Biopharmaceuticals and Bioprocessing segments. The Biopharmaceuticals segment involves molecule discovery, development, and licensing activities. The Bioprocessing segment includes contract development and manufacturing services for recombinant proteins. The company was founded on April 17, 2008 and is headquartered in Bryan, TX.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q1 2025

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

iBio, Inc. is an AI-driven innovator that develops next-generation biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard to target cancers, and other diseases. It focuses on decreasing drug failures, shortening drug development timelines and opening up new frontiers against the most promising targets. The company was founded on April 17, 2008 and is headquartered in San Diego, CA.

The stock price of iBio (IBIO) fell by 32.28% in the most recent trading session. This is why.

iBio (IBIO) Stock: Why It Plummeted 32.28%

iBio, Inc. (NYSE:IBIO ) Q4 2022 Earnings Conference Call September 27, 2022 4:30 PM ET Company Participants Stephen Kilmer - Investor Relations Tom Isett - Chairman and Chief Executive Officer Rob Lutz - Chief Financial and Business Officer Martin Brenner - Chief Scientific Officer Conference Call Participants Kristen Kluska - Cantor Roy Buchanan - JMP Securities Operator Thank you for standing. And welcome to the iBio Fiscal Year 2022 Results Conference Call.

iBio, Inc. (IBIO) Q4 2022 Results - Earnings Call Transcript

BRYAN, Texas and SAN DIEGO, Sept. 27, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable FastPharming ® Manufacturing System, today announces preliminary unaudited financial results for the fiscal year ended June 30, 2022, and provides a corporate update.

iBio Reports Preliminary Unaudited Fiscal Year 2022 Financial Results and Provides Corporate Update

– Positions Company for leadership in AI-powered drug discovery –

iBio Acquires RubrYc Therapeutics' AI Drug Discovery Platform and Pipeline

Eos Energy Enterprises

Express

Hyzon Motors

New Age Beverages

Electrameccanica

The Metals Co

The first half of 2022 for the stock market was the worst since 1970. Consequently, investors are forced to re-evaluate their portfolios and discard risky assets.

7 Penny Stocks to Sell Before They Go to Zero

Boxed

Verastem

Here's three penny stocks to watch in July 2022 The post 3 Top Penny Stocks to Add to Your July 2022 Watchlist  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Top Penny Stocks to Add to Your July 2022 Watchlist

Sonnet BioTherapeutics

China Rapid Finance

Which penny stocks are you watching right now? The post Hot Penny Stocks to Buy in Mid-June 2022?

Hot Penny Stocks to Buy in Mid-June 2022? 3 to Watch

Digital Brands Group Inc

Tonix Pharmaceuticals Hld

Here's what you need to know about trading penny stocks on May 23rd The post What to Know About Buying Penny Stocks on May 23rd  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

What to Know About Buying Penny Stocks on May 23rd

iBio, Inc. (NYSE:IBIO ) Q3 2022 Results Conference Call May 12, 2022 4:30 PM ET Company Participants Stephen Kilmer - Investor Relations Tom Isett - Chairman and Chief Executive Officer Rob Lutz - Chief Financial and Business Officer Conference Call Participants Roy Buchanan - JMP Securities Operator Good day and thank you for standing. Welcome to the iBio Fiscal 2022 Third Quarter Financial Results Conference Call.

iBio, Inc. (IBIO) CEO Tom Isett on Q3 2022 Results - Earnings Call Transcript

BRYAN, Texas, May 12, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable FastPharming ® Manufacturing System, today announces its financial results for the fiscal quarter ended March 31, 2022 and provides a corporate update.

iBio Reports Fiscal Third Quarter 2022 Financial Results and Provides Corporate Update

BRYAN, Texas, May 05, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System®, announced today that it will report its fiscal 2022 third quarter financial results after market close on Thursday, May 12, 2022. iBio management will host a webcast and conference call at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update.

iBio to Report Fiscal 2022 Third Quarter Financial Results and Provide Corporate Update on Thursday, May 12, 2022

Creative Medical Technology Holdings

Rigel Pharmaceuticals

Here's what you need to know about trading penny stocks in April The post How to Trade Penny Stocks in April 2022 and 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

How to Trade Penny Stocks in April 2022 and 3 to Watch

Avenue Therapeutics

Clearside Biomedical

Check these three biotech penny stocks out for your watchlist The post Top Biotech Penny Stocks to Buy Now? 3 to Watch in March  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Top Biotech Penny Stocks to Buy Now? 3 to Watch in March

BRYAN, Texas, March 11, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System®, today announced that its Chairman & CEO, Tom Isett, will present virtually at the Oppenheimer 32nd Annual Healthcare Conference on Thursday, March 17, 2022 at 2:40 p.m. Eastern Time.

iBio to Participate in the Oppenheimer 32nd Annual Healthcare Conference

iBio, Inc. (IBIO) CEO Tom Isett on Q2 2022 Results - Earnings Call Transcript

BRYAN, Texas, Feb. 14, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable FastPharming Manufacturing System®, today announces its financial results for the fiscal quarter ended December 31, 2021 and provides a corporate update.

iBio Reports Fiscal Second Quarter 2022 Financial Results and Provides Corporate Update

BRYAN, Texas, Feb. 07, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System®, announced today that it will report its fiscal 2022 second quarter financial results after market close on Monday, February 14, 2022. iBio management will host a webcast and conference call at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update.

iBio to Report Fiscal 2022 Second Quarter Financial Results and Provide Corporate Update on Monday, February 14, 2022

iBio Inc received the FDA response to its pre-investigational new drug (IND) package for IBIO-202, the Company's lead COVID-19 vaccine program.

iBio Advances Its Vaccine Program for Multi-Variant COVID-19 Disease

BRYAN, Texas, Jan. 04, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System®, today announced that it will participate in the H.C. Wainwright BioConnect Conference, to be held virtually January 10-13, 2022.

iBio Announces Participation in the H.C. Wainwright BioConnect Conference

- Shareholders Continue to Support Reverse Split and Authorized Share Proposals by a 2-to-1 Margin - - Shareholders Continue to Support Reverse Split and Authorized Share Proposals by a 2-to-1 Margin -

iBio Announces Partial Adjournment of Annual Meeting of Shareholders to January 31, 2022

BRYAN, Texas, Dec. 21, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based  FastPharming  Manufacturing System®, provides the following link to listen virtually to the 2021 Annual Shareholders meeting: www.virtualshareholdermeeting.com/IBIO2021. The meeting will be held at 9:00 AM EST on December 22, 2021.

iBio Provides Information for Listening to the Virtual Annual Stockholder Meeting

- Shareholders Presently Supporting Reverse Split and Authorized Share Proposals by a 2-to-1 Margin -

iBio Announces Partial Adjournment of Annual Meeting to December 22

Palatin Technologies

Qualigen Therapeutics

Trading biotech penny stocks right now? Check these three out The post Hot Biotech Penny Stocks to Buy Today?

Hot Biotech Penny Stocks to Buy Today? 3 For Your December Watchlist

- iBio's Board Urges Shareholders to Vote Today to Support Company's Strategic Growth Plans -

ISS Joins Glass Lewis in Recommending Shareholders Vote “FOR” All Proposals Ahead of iBio's Upcoming Annual Meeting

The stock price of iBio Inc (NYSEAMERICAN: IBIO) increased by 29.15% in the most recent trading session. This is why it happened.

News for iBio Stock (IBIO)